Latest Options News

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Core Energy Minerals has initiated its first aircore drilling program at the Cummins Uranium Project in South Australia, while confirming uranium mineralisation in Brazil and refinancing its convertible notes to support ongoing exploration.

Sunshine Metals Limited reported a cautious quarterly cash flow with A$1.9 million in cash and 1.4 quarters of funding runway, highlighting the discretionary nature of its exploration activities and plans to secure further financing.

IRIS Metals has raised $4.267 million through a share placement to fund lithium exploration and development in South Dakota, aiming for a feasibility study completion by early 2026.

Cobre Limited reports strong metallurgical results from its Botswana copper projects alongside a successful AU$1.68 million capital raising, setting the stage for upcoming resource estimates and environmental approvals.

Rokeby Resources has completed its acquisition of Stunalara Metals, securing promising gold-copper-antimony tenements, and commenced a maiden drilling campaign at the Hurricane Project in Queensland.

Dotz Nano has partnered with CarbonCapture Inc. to scale its high-performance direct air capture sorbent, while raising AU$1.2 million to fund its DotzEarth project amid ongoing funding timing challenges.

Blue Star Helium has raised A$4.5 million through a strategic institutional placement to fund the final stages of its Galactica helium project, aiming for production by late 2025.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

Zuleika Gold Limited has scheduled a pivotal trial in October 2025 to resolve damages claims against Catalyst Metals Limited, while advancing exploration plans at its key Western Australian projects.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.